Variant report
Variant | nsv882488 |
---|---|
Chromosome Location | chr5:100633738-100665557 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1459583 | chr5:100633738-100633739 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs530460457 | chr5:100633763-100633764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114608562 | chr5:100633776-100633777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs13156375 | chr5:100633787-100633788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560499988 | chr5:100633790-100633791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373918347 | chr5:100633817-100633818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529896654 | chr5:100633840-100633841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370537561 | chr5:100633860-100633861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs397792414 | chr5:100633872-100633873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552408101 | chr5:100633898-100633899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs80014496 | chr5:100633902-100633903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138507978 | chr5:100633928-100633929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549604195 | chr5:100633931-100633932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371750141 | chr5:100633944-100633945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149893370 | chr5:100634049-100634050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9654535 | chr5:100634067-100634068 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs535385880 | chr5:100634071-100634072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10043874 | chr5:100634083-100634084 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs1350620 | chr5:100634088-100634089 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs182235192 | chr5:100634099-100634100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557572128 | chr5:100634134-100634135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554655568 | chr5:100634161-100634162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544812028 | chr5:100634162-100634163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560184431 | chr5:100634184-100634185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556842929 | chr5:100634199-100634200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575164276 | chr5:100634205-100634206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs199972985 | chr5:100634223-100634224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs5869941 | chr5:100634224-100634225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200414637 | chr5:100634225-100634226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs3066339 | chr5:100634235-100634236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs397884135 | chr5:100634238-100634239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs542574860 | chr5:100634287-100634288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187553740 | chr5:100634296-100634297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527687686 | chr5:100634334-100634335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549617248 | chr5:100634390-100634391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs143992368 | chr5:100634403-100634404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527540633 | chr5:100634449-100634450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564415106 | chr5:100634462-100634463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375600484 | chr5:100634500-100634501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537731017 | chr5:100634503-100634504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58679950 | chr5:100634507-100634508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371433696 | chr5:100634533-100634534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200979602 | chr5:100634578-100634579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs61104972 | chr5:100634579-100634580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1545683 | chr5:100634600-100634601 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs531601595 | chr5:100634613-100634614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556749139 | chr5:100634615-100634616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567945764 | chr5:100634647-100634648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529116512 | chr5:100634648-100634649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs547308605 | chr5:100634649-100634650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:100627400-100640200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:100640200-100640600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:100640600-100641000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:100641200-100641400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr5:100641200-100642000 | Enhancers | A549 | lung |
6 | chr5:100642000-100642200 | Flanking Active TSS | A549 | lung |
7 | chr5:100642200-100642600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr5:100642200-100642600 | Active TSS | A549 | lung |
9 | chr5:100642200-100642800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr5:100642600-100643000 | Flanking Active TSS | A549 | lung |
11 | chr5:100643000-100643600 | Enhancers | A549 | lung |
12 | chr5:100647400-100650800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr5:100647600-100648400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr5:100647600-100648400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
15 | chr5:100650600-100651000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr5:100650800-100651000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr5:100651000-100652400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr5:100651000-100652800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr5:100652400-100653400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr5:100652800-100653200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr5:100653200-100656200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr5:100656200-100657000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
23 | chr5:100656400-100657000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
24 | chr5:100665200-100665800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |